Table 1.

Targeted Drugs Approved for Colorectal Cancer

Drug class	Drug	Route of administration
VEGF inhibitors	Bevacizumab Ramucirumab Ziv-aflibercept	Intravenous Intravenous Intravenous
EGFR inhibitors	Cetuximab Panitumumab	Intravenous Intravenous
Kinase inhibitors	Regorafenib	Oral

EGFR indicates epidermal growth factor receptor; VEGF, vascular endothelial growth factor.